Filtros de búsqueda

Lista de obras de Catherine Thieblemont

<sup>18</sup>F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

artículo científico publicado en 2022

A MALT lymphoma prognostic index generated from the dataset of the IELSG-19 prospective clinical trial

artículo científico

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

artículo científico publicado en 2015

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial

artículo científico publicado en 2013

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

artículo científico publicado en 2016

A tumor volume and performance status model to predict outcome prior to treatment in diffuse large B-cell lymphoma

artículo científico publicado en 2022

Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse

artículo científico publicado en 2015

Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival

artículo científico publicado en 2013

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

artículo científico publicado en 2013

Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma ⬇️

artículo científico publicado el 5 de marzo de 2011

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

artículo científico publicado en 2011

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

scientific article published on 01 August 2018

An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement

artículo científico publicado en 2005

Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma

artículo científico publicado en 2019

Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

artículo científico publicado en 2005

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

artículo científico publicado en 2020

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

artículo científico publicado en 2019

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

artículo científico publicado en 2014

Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?

artículo científico publicado en 2016

At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity

artículo científico publicado en 2013

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

article by Frédéric Peyrade et al published May 2011 in Lancet Oncology Commission

Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

scientific article published on 01 January 2019

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial

artículo científico

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

artículo científico publicado en 2013

Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients

artículo científico publicado en 2014

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

artículo científico publicado en 2016

Burden of illness of follicular lymphoma and marginal zone lymphoma

article

CD19-directed CAR T-cell therapy in B-cell NHL

artículo científico publicado en 2020

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases

artículo científico publicado en 2009

Calcium channel blockers impair the antitumor activity of anti-CD20 monoclonal antibodies by blocking EGR-1 induction

artículo científico publicado en 2020

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.

artículo científico publicado en 2018

Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination

artículo científico publicado en 2017

Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review

scientific article published on 19 September 2020

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

artículo científico publicado en 2005

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type

artículo científico

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

scientific article published on 07 May 2020

Clinical aspects and therapy of gastrointestinal MALT lymphoma

artículo científico publicado en 2017

Clinical presentation and management of marginal zone lymphomas

artículo científico publicado en 2005

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis

artículo científico publicado en 2006

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

artículo científico publicado en 2005

Combination of chemotherapy and monoclonal antibodies for the treatment of lymphoma

artículo científico publicado en 2002

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

artículo científico publicado en 2014

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study

artículo científico publicado en 2015

Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients

artículo científico publicado en 2011

Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival

artículo científico publicado en 2008

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

artículo científico publicado en 2017

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network

artículo científico publicado en 2014

Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.

artículo científico publicado en 2016

Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews

artículo científico publicado en 2020

Curing diffuse large B-cell lymphomas in elderly patients

artículo científico publicado en 2018

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

artículo científico publicado en 2010

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

artículo científico publicado en 2015

Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma

artículo científico publicado en 2020

Description of neurotoxicity in a series of patients treated with CAR T-cell therapy

scientific article published on 04 November 2020

Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.

artículo científico publicado en 2016

Diagnostic value of permeative invasion radiologic pattern in sinonasal lymphomas

artículo científico publicado en 2022

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.

artículo científico publicado en 2010

Discovery of Human-Similar Gene Fusions in Canine Cancers

artículo científico publicado en 2017

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

artículo científico publicado en 2013

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

scientific article published on 01 November 2020

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment

artículo científico publicado en 2020

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma

artículo científico publicado en 2022

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

artículo científico publicado en 2010

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

artículo científico publicado en 2018

Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.

artículo científico publicado en 2016

Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases

artículo científico publicado en 2012

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.

artículo científico publicado en 2016

Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis.

artículo científico publicado en 2009

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

artículo científico publicado en 2015

Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma

artículo científico publicado en 2007

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

artículo científico publicado en 2017

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

artículo científico publicado en 2019

G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma

artículo científico publicado en 2020

GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors

artículo científico publicado en 2019

Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH).

artículo científico publicado en 2017

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

artículo científico publicado en 2007

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

artículo científico publicado en 2013

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

scientific article published on 29 November 2010

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

artículo científico publicado en 2018

Hairy Cell Leukemia: Results of the French Retrospective Cohort After 10 Years of Follow Up

artículo científico publicado en 2019

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

artículo científico publicado en 2016

Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis

scientific article published on 14 December 2019

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

artículo científico publicado en 2015

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

artículo científico publicado en 2018

Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients

artículo científico publicado en 2017

Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation

artículo científico publicado en 2012

Ibrutinib: A new drug of B-cell malignancies

artículo científico publicado en 2015

Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

scientific article published on 02 October 2020

Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry

artículo científico publicado en 2011

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer

artículo científico publicado en 2020

Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.

artículo científico publicado en 2017

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

artículo científico publicado en 2020

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

artículo científico publicado en 2016

Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma

artículo científico publicado en 2014

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

artículo científico publicado en 2017

Lenalidomide in diffuse large B-cell lymphoma

artículo científico publicado en 2012

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

artículo científico publicado en 2019

Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma

artículo científico publicado en 2015

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

artículo científico publicado en 2014

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

artículo científico publicado en 2010

Lymphoma in older patients

artículo científico publicado en 2007

Lymphomas with kidney involvement: the French multicenter retrospective LyKID study

artículo científico publicado en 2020

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin

artículo científico publicado en 2018

MALT lymphomas: pathogenesis can drive treatment.

artículo científico publicado en 2011

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

artículo científico publicado en 2012

MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?

artículo científico publicado en 2013

Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).

artículo científico publicado en 2004

Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.

artículo científico publicado en 2014

Management of aggressive lymphoma in very elderly patients.

artículo científico publicado en 2017

Management of marginal zone lymphomas

artículo científico publicado en 2006

Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study

artículo científico publicado en 2015

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

scientific article published on 21 September 2020

NF-κB in the New Era of Cancer Therapy

artículo científico publicado en 2020

Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma

artículo científico publicado en 2012

Non-MALT marginal zone lymphoma

scientific article published on July 2011

Non-gastric extranodal marginal zone lymphomas: a challenge in routine practice

artículo científico publicado en 2008

Nongastric mucosa-associated lymphoid tissue lymphomas

artículo científico publicado en 2003

Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study.

artículo científico publicado en 2013

Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.

artículo científico publicado en 2013

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

scientific article published on 08 July 2019

Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA

artículo científico publicado en 2020

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas

artículo científico publicado en 2021

Optimizing initial therapy in DLBCL

scientific article published on 07 August 2018

Optimizing therapy for nodal marginal zone lymphoma

artículo científico publicado en 2016

Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001.

artículo científico publicado en 2003

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry

Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma.

artículo científico publicado en 2014

PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP

artículo científico publicado en 2015

Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation

artículo científico publicado en 2013

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

artículo científico publicado en 2019

Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.

artículo científico publicado en 2014

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2015

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients.

artículo científico publicado en 2012

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

artículo científico publicado en 2015

Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.

artículo científico publicado en 2009

Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

article

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

artículo científico publicado en 2020

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients

scientific article published on 07 September 2019

Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort

scientific article published on 13 August 2020

Primary cutaneous marginal zone lymphoma

artículo científico publicado en 2009

Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting

scientific article published on 28 October 2016

Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.

artículo científico publicado en 2004

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

artículo científico publicado en 2016

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

artículo científico publicado en 2019

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

artículo científico publicado en 2016

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers

artículo científico publicado en 2020

Quantification of Idelalisib in Human Plasma by Ultra-Performance Liquid Chromatography Coupled to Mass Spectrometry in Negative Ionization Mode.

artículo científico publicado en 2018

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2019

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

scientific article published on 02 June 2016

Report of the 14th International Conference on Malignant Lymphoma (ICML) closed workshop on future design of clinical trials in lymphomas.

artículo científico publicado en 2018

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

artículo científico publicado en 2017

Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases

artículo científico publicado en 2014

Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma

artículo científico publicado en 2010

Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy

artículo científico publicado en 2015

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

artículo científico publicado en 2011

Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA

artículo científico publicado en 2020

Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud

artículo científico publicado en 2004

Second-line treatment paradigms for diffuse large B-cell lymphomas

scientific article published on September 2009

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

artículo científico publicado en 2020

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

artículo científico publicado en 2003

Specific renal infiltration by aggressive lymphoma mimicking tumor lysis syndrome

artículo científico publicado en 2019

Splenic marginal zone lymphoma: current knowledge and future directions.

artículo científico publicado en 2012

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity

artículo científico publicado en 2003

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

artículo científico publicado en 2007

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

artículo científico publicado en 2020

Tailoring treatment for MALT lymphoma patients: where do we stand now?

artículo científico publicado en 2017

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

artículo científico publicado en 2017

Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial

artículo científico publicado en 2012

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

artículo científico publicado en 2018

The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study

artículo científico publicado en 2011

Therapy-related classical Hodgkin lymphoma after a primary haematological malignancy: a report on 13 cases

artículo científico publicado en 2012

Treatment for patients with indolent and mantle cell lymphoma

artículo científico publicado en 2013

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

scientific article published on 05 December 2019

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients

artículo científico publicado en 2002

Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique

VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers

artículo científico publicado en 2017

Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group

artículo científico publicado en 2020

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/

artículo científico publicado en 2014

[The risk of lymphoma in Sjögren's syndrome]

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda